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Abstract
In the past few years, interest in the human microbiome has grown, and its role in disease
prevention and development is just now becoming evident. The oral microbiome is of particular
interest to scientists due to the presence of pathogens in a highly vascular cavity. The oral
pathogens produce no antibody response by the immune system until an inflammatory event
spurs the immune system to react. How is it that pathogenic microbes reside in the oral cavity
without being targeted by the immune system? It is common for people to have Streptococcal
mutans, and other pathogens as part of the oral microbiota. There are those who “carry” S
mutans, or Staphylococcus aureus, and other pathogenic microbes, and do not seem to get sick;
although they are able to infect others. How is it that their immune system tolerates those
pathogenic microbes? A hypothesis that might explain immune ‘tolerance,’ is that the immune
system labels the microbes as ‘self’ instead of ‘foreign.’ Many are familiar with this concept in
the realm of cancer cells. The immune system labels cancer cells as ‘self,’ and is unable to
identify and destroy them. Exposure to pathogenic microbes may elicit an immune response but
possibly people who 'carry' pathogenic microbes as part of their natural microbiota do so because
their immune system identifies those microbe as ‘self.’ They could still become sick by this
pathogen, if for example, there is a microbial imbalance and S. Mutans invaded the tonsils. If
other non-pathogenic microbiota replicated enough to dominate the area, the infection would
resolve. The immune system would not be able to kill it, if it could not identify it as ‘self.’ If this
were the case, the microbiome would be more influential in the progression, or halting of the
disease process.
Research studies show that many bacteria have developed the capacity to evade the
immune system. Virulence factors help in the evasion process, and are many and varied.
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However, the hypothesis explored in this paper looks into another possible explanation for
pathogenic microbes not being detected by the immune system. It is hypothesized that some
pathogens of the oral and skin microbiota are identified as ‘self’ by the immune system.
Implications of oral pathogens being identified as ‘self,’ could be; uninhibited access to the body.
Their toxins could produce an antibody response, but the bacteria would not be identified and
eliminated. This could result in chronic, unresolved inflammation, plaque build-up and tissue
destruction, especially in the case of periodontitis which will be examined in greater detail in this
paper.
Atherosclerosis, rheumatoid arthritis, dementia, periodontitis, and other chronic
inflammatory diseases have been linked to pathogens of the oral microbiome. Studies need to be
done to determine if the pathogens, or bacterium that are implicated in those diseases elicit an
immune response. Certain research studies show that toxins produced from certain microbes
produce an antibody response, but the bacterium itself does not. If the body only responds to the
toxins and not to the bacteria, this would create a situation of chronic inflammation. Antibodies
would be sent to destroy the toxins, and the bacteria would continue to replicate and produce
more toxins, which would lead to increased pain, swelling, and tissue destruction for the affected
individual. More studies need to be done to determine if the immune system does not respond to
the bacterium involved in chronic inflammatory conditions.
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Detection of Microbiome Pathogens by the Immune System
The term microbiome has been defined as a community of commensal, symbiotic, and
pathogenic micro-organisms that inhabit our bodies (Duzgunes, N., 2016). Nobel Laureate
Joshua Lederberg helped define microbiome, and stated that the microorganisms of the
microbiome “have been all but ignored as determinants of health and disease” (Duzgunes, N.
2016, p. 151). The oral microbiome has been identified as a source of pathogens that cause
disease in other areas of the body. Endocarditis, atherosclerosis, rheumatoid arthritis and other
diseases have been linked to oral pathogens (Gehrig, & Willman, 2016).
The Human Microbiome
Bacteria and other microorganisms colonize the mucous membranes of the respiratory
tract, the oral cavity, the digestive tract and the skin surface. Bacteria and other organisms that
are found in these areas and are not causing infection or disease, are known as normal flora.
Normal flora may include commensal bacteria and pathogenic bacteria, fungi and even viruses
(VanMeter, VanMeter, & Hubert, 2010). Microbes inhabiting the body will migrate to areas that
favor their survival and replication. In the case of oral microflora, it is likely that there are over
700 common oral microbial species (Duzgunes, N. 2016). The normal flora protects the body
against disease-causing pathogens by preventing their attachment to the host. Having a diverse
microbiome has been associated with a state of health. This is due to the fact that the microbes
on the body are competing for nutrients. The greater the variety of microbes, the less likely it is
that a pathogenic microbe will out-compete the others for nutrients and replicate to the extent
that it will initiate disease in the host. The fewer the microbes that a host carries, the more likely
it is that a pathogenic microbe forming part of the normal flora, or encountered in the
environment, will attach, replicate and cause disease. The pathogen that forms part of the normal
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microbiota and causes disease under certain conditions is known as an opportunistic pathogen
(VanMeter, VanMeter, & Hubert, 2010).
The microbiota of the body has resident flora, which are microbes that remain with the
person their entire lifespan. Escherichia coli is one of those microbes. The body benefits from
the presence of E. coli in the large intestine since it helps to breakdown nutrients to release
vitamins. (Gehrig, & Willman, 2016). Strep sanguines, is a bacterium which helps prevent
caries, while Propionibacterium acnes aids in the production of cobalamin and short chain fatty
acids (Jimenez, et al., 2005). Other microbes are not beneficial, such as Strep mutans, which has
been implicated in caries and heart disease, and Aggregatibacter actinomycetecomitans, which
can damage gingival tissues and is present in many cases of periodontal disease (Gehrig, &
Willman, 2016). Transient flora, are temporary residents that may survive only a few hours or
months. Any new microbe that attaches to the host will have to compete with other microbes for
nutrients, and will have to deal with the immune system’s response if detected. The new microbe
might also be eliminated if the environment changes in a chemical or physical way and is no
longer conducive to survival. (Gehrig, & Willman, 2016.)
Acquisition of the Microbiome
There is no clear answer as to how we initially acquire our oral microbiota. It has been
suggested that we acquire it after birth from our mothers, first as we pass through the vaginal
canal, and second, through skin to skin contact, and skin to mouth transmission through feeding
(VanMeter, K., VanMeter, W., & Hubert, 2010). Newborns are also exposed to microbes in the
air. As infants breathe, microbes enter the mucous membranes of the lungs. Transfer of S. salivar
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ius, S. mutans, and other microbes have been shown to have been passed through saliva,
from mother to child, and through contact within family groups (Marsh & Martin, 2009). Some
studies indicate that babies are exposed to bacteria even before birth (Jimenez, et al, 2005).
As microbes invade a newborn baby’s body, it is hypothesized that the immune system is
immature, and is not able to distinguish ‘self’ from ‘non-self’ cells. Another explanation would
be that since mother and baby were one, the microbiome shared with mom is labeled as ‘self.’ In
any case, microbes that are part of the initial invasion, may be labeled as ‘self,’ by the immature
immune system. More studies need to be done regarding this hypothesis.
Pathogens of the microbiome are involved in producing hormones and vitamins that are
needed to survive, but they are also linked to diseases involving chronic inflammation such as
periodontal disease, atherosclerosis, rheumatoid arthritis, and many others (Gehrig & Willman,
2016).
The Oral Microbiota and Periodontal Disease
Periodontal disease is not curable. It is the destruction of the gingiva, periodontal fibers
and alveolar bone of the periodontium. The bacteria that cause it can be reduced through use of
antibiotics or mechanical removal. The current theory on periodontal disease proposes that the
presence of plaque biofilm is necessary for disease initiation. This theory puts forth the idea that
initial inflammation to plaque causes gingivitis, and the host response to the bacteria causes
progression from gingivitis to periodontitis. It proposes that the inflammation within the
subgingival tissues is caused by the host response which drives the changes in the microbial
composition of the biofilm (Gehrig, & Willman, 2016). It is hypothesized that the process for
developing periodontal disease may be as follows. Inadequate oral hygiene, which results in
accumulation of plaque and calculus due to bacteria proliferation. When cells die they release
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cytokines which attract neutrophils. Neutrophils migrate to the area damaged by periodontal
infection and try to clean up the damaged cell area, the acidic waste products, and the bacteria.
However, the biofilm composition and other factors make it difficult for the immune system to
destroy the bacteria. Neutrophils may cause additional damage because after phagocytosing the
damaged tissue and toxins, they die, and the lysosomal enzymes they carry are released, causing
additional tissue damage. (Ibsen, & Anderson-Phelan, 2018) Neutrophils at the site decrease
following acute inflammation, and macrophage, lymphocytes, and plasma cells increase.
Macrophages remove tissue debris, and can also present on the surface the cause of the
inflammation. Macrophages present the antigen to T lymphocyte cells and B lymphocyte cells.
Dendritic cells in the oral mucosa also play a role in processing antigens and displaying them on
their surface to T cells and B cells. The B-memory and T-memory lymphatic cells have the
ability to ‘remember’ the antigen. They duplicate themselves many times over in a process called
clonal selection. The next time they encounter the antigen they alert the immune system and the
plasma cells to release a copy of a protein that is made to respond to the bacteria. The proteins
released are antibodies which, when circulating in the blood, are also known as
immunoglobulins. In the case of inflammation, an antibody titer can be drawn to determine how
many antibodies are circulating in the bloodstream. Elevated levels of antibodies indicate the
immune system is fighting against identified antigens. (Ibsen, & Anderson-Phelan, 2018) If the
immune response were unable to identify and target the bacterium that was producing toxins, it
could target the toxins and try to destroy them. The bacterium itself could continue to grow and
reproduce while the immune system targeted the wrong ‘invader’.
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Destruction of the Periodontium
Periodontal disease that is not controlled, will result in destruction of the gingiva,
periodontal fibers, and alveolar bone, which will result in tooth loss. Gram negative bacteria are
part of mature plaque biofilm. Besides toxic waste products that can change the pH of a
microenvironment, these gram-negative bacteria have an endotoxin called lipopolysaccharide,
(LPS) found on the outer membrane, that could be responsible for initiating inflammation in
gingival tissues. LPS is released if the cell is lysed or through vesicles released into the
surrounding periplasm. LPS plays a major role in provoking disease states, and is able to elicit
fever and apoptosis. Pathogenic bacteria also have the ability to produce enzymes, such as
collagenase which can break down collagen and proteases which can break down proteins that
are part of the periodontal structure. (Gehrig, & Willman, 2016). The immune system will also
contribute to periodontal destruction. Cytokines, prostaglandins and matrix metalloproteinases
(MMPs) are biochemical mediators that activate the immune response, and have the potential to
initiate tissue destruction, in an effort to rid the body of the pathogenic agent. Periodontal disease
causes a local inflammatory effect, and a systemic inflammatory effect (Noble & Papapanou,
2013). In chronic inflammatory disease, cytokines are known to initiate tissue destruction;
prostaglandins initiate most of the alveolar bone destruction, and MMPs may cause extensive
collagen damage. (Gehrig, & Willman, 2016).
Porphyromonas Gingivalis and the Link to Periodontal Disease and Rheumatoid Arthritis
Bacterial pathogens produce acidic waste products and other virulence factors that help
them evade detection by the immune system. Porphyromonas gingivalis is a gram-negative
bacterium, commonly found in periodontal infections. P. gingivalis is able to produce many
virulence factors, lipopolysaccharide (LPS), and proteolytic enzymes, which cause cell damage
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and provoke inflammation, cytokine response, and immune system activation. P gingivalis also
produces an enzyme called peptidylarginine deiminase or PPAD. This enzyme produces
citrullinated epitopes (proteins) (Potempa, Mydel, & Koziel, 2017). An epitope is the part of the
cell that is recognized by the immune system as ‘self’ or ‘foreign’. If identified as ‘foreign’, the
antibody will bind to the epitope, and start the immune system removal process (VanMeter,
VanMeter, & Hubert, 2010). Citrullination is the conversion of arginine, an amino acid, into
citrulline, which is recognized as an antigen, by antibodies in the immune system. Only PPAD is
able to deiminate C-terminal arginine proteins. Therefore, the production of the enzyme indicates
the presence of P gingivalis. It also demonstrates how P gingivalis may provoke the immune
system into attacking otherwise healthy cells. It is also of interest to note that PPAD
autocitrullinates itself, converts itself into a target, and provokes an augmented response from the
immune system, which helps create an inflammatory environment that benefits P. Gingivalis.
The destruction of otherwise healthy tissue by the immune system is common in auto-immune
diseases. Along with periodontal disease, other diseases such as rheumatoid arthritis,
Alzheimer’s, psoriasis, nephropathy, and multiple sclerosis have been associated with
citrullination of proteins (Potempa, Mydel, & Koziel, 2017). ACPA was found to bind to
receptors in the joints and was specific to the P. gingivalis bacterium involved in rheumatoid
arthritis. Serum levels of ACPAs have been found to co-relate with periodontitis activity in
otherwise healthy adults. (Potempa, Mydel, & Koziel, 2017). The presence of the enzyme
produced by the bacteria, PPAD, indicate that the initiator of the antibody immune response is
the product of P. gingivalis. The immune response seems to be directed against the enzyme
produced, not the bacterium itself. This is important to the hypothesis that individuals with
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chronic inflammation, may have bacteria that are identified by the immune system as ‘self’.
More studies need to be done to determine if this is the case.
Anti-citrullinated antibodies or ACPAs were found in 70% of people with rheumatoid
arthritis (Potempa, Mydel, & Koziel, 2014). Once the cells have been affected by this enzyme,
the immune system will target them for removal (Araújo, M., Melo, I., & Lima, V., 2015) It was
found that ACPA in the gingiva precedes rheumatoid involvement by sometimes up to ten years.
Rheumatoid arthritis involves chronic inflammation, and the study by Potempa, Mydel and
Koziel (2017), reported that serum levels of ACPA from P. gingivalis in rheumatoid arthritis,
were elevated. Rheumatoid factor and the resulting immune complexes, inflammatory cytokine
production, and macrophage and dendritic activation, resulted in tissue damage. ACPA was not
found in other degenerative diseases of the joints. Just as in periodontal disease, the chronic
inflammation of rheumatoid arthritis resulted in progressive bone destruction (Potempa, Mydel,
& Koziel, 2017). Rheumatoid arthritis is considered an inflammatory autoimmune disease, while
periodontal disease is considered an immunoinflammatory disease of bacterial origin (Araujo,
Melo & Lima, 2015).
A cohort study of almost 700 patients, found that patients with rheumatoid arthritis did
not have higher anti-P gingivalis antibody titers than controls without rheumatoid arthritis. In
the study, an anti-P gingivalis assay that detected antibodies to P gingivalis LPS was used. LPS
is a toxin produced by P gingivalis, and the author noted the inadequacy of the test. It was
mentioned that there are many tests for P gingivalis, but none of those methods, including the
one used, was able to detect current P gingivalis infection. According to the author, the only
method that would be able to prove P. gingivalis infection, would be the direct detection of the
bacteria (Seror, et al., 2015). In another study, patients with rheumatoid arthritis were tested for
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exposure to P. Gingivalis and were found to have a 78% exposure rate to the bacterium. The
healthy control group was also tested for exposure to P. Gingivalis and they had an 83%
exposure rate. (Scher, et al, 2012) Many tests used to determine the presence of bacteria, or past
encounters with bacteria, test for serologic immune reactions to different toxins produced by
bacteria. The method of detection of bacterial infection is important, because it may show a clear
antibody response to toxins of bacteria, but not to the bacterium itself.
In the article, The Link Between Periodontal Disease and Rheumatoid Arthritis: An
Updated Review, by Joanna Koziel & Piotr Mydel & Jan Potempa, it was stated, ‘Similar to
infection with P. intermedia, inoculation with either heat killed P. gingivalis or the purified cell
membrane fraction from the same organism had no effect on either the rate or the
severity of CIA (collagen-induced arthritis model). Taken together, these findings indicate the
requirement for live P. gingivalis, which releases bacterial factors exerting a direct or indirect
(via stimulation of host systems) effect on the host that ultimately triggers an autoimmune
reaction’ (Potempa, Mydel, & Koziel, 2014). The article itself seems to be stating that the
immune system does not respond to the lysed bacterium, P. Gingivalis. It is interesting to note
that many vaccines work by introducing a lysed or attenuated bacterium into the body along with
an adjuvant. Usually, the lysed bacterium alone is not enough to produce an immune response.
The bacterium must also be accompanied by a substance that causes inflammation or irritation.
This substance is the adjuvant and the irritation it produces, is what causes an immune response.
A vaccine is effective when the body identifies the bacterium with the inflammatory substance
and produces antibodies to the bacterium (Centers for Disease Control and Prevention,
Understanding How Vaccines Work, 2013, Vaccine Adjuvants).
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According to the book, Oral Pathology for the Dental Hygienist (2018), the toxins
produced by bacteria, may be labeled as antigens by the immune system. Pathogens are normally
identified as foreign but in some diseases the body mistakenly identifies as ‘self,’ things that are
not (Ibsen, & Anderson-Phelan, 2018). Studies need to be done to investigate the possibility that
some microbes, possibly those from our initial microbiome, don’t provoke an immune response.
The Oral Microbiota and Heart Disease
Strep mutans, commonly found in the oral cavity, is another one of the pathogens that can
cause endocarditis, and has been linked to atheromatous plaques in the heart valves and arteries.
In a study from the Journal of Clinical Microbiology, researchers tested 35 heart valves and 27
atheromatous plaque specimens and compared them to those in dental plaque samples from the
same subjects. In the heart valve tissues, streptococcal species were found in 77.8% of the
subjects, and they accounted for 59.4% of the bacterial population. In the atheromatous plaque
specimens,’ streptococcal species were detected at 88.9% frequency, with an 81.1% quantity.
Strep mutans dominated the species and was found to have a 77.8% frequency and to form
48.1% quantity of the atheromatous plaque specimens. The study speculates that S. mutans could
be a causative agent for cardiovascular disease. It related that several studies had documented the
presence of periodontal related bacteria in atheromatous samples. S. mutans proliferation in the
oral cavity resulted in increased plaque and calculus formation, and in the arteries and heart it
was linked to atheromatous plaque build-up (Nakano, K., et al., 2006).
In the 2011 study by Koren, et al. (p.4592-4598) researchers studied human oral, gut and
plaque microbiota in patients with atherosclerosis. Biopsies of atheromas removed from arteries
showed the presence of Streptococcus and Veillonella. Those were also seen in oral microbiota,
and the combination of the two have been shown to contribute to plaque and calculus formation.
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Researchers hypothesized that the “pathobiology of the atherosclerotic plaque may be similar to
that of dental plaque” (Koren, et al., 2011, p.4595). This study also identified the presence of
Chryseomonas bacteria in all of the atheromas along with other types of bacteria. The report
concluded that their findings supported the hypothesis that the oral cavity and the gut microbiota
could be sources for bacteria associated with atherosclerotic plaque. They identified many
bacteria common in the oral and gut cavity that were also present in atheromatous plaques. The
study however, did not attribute microbial bacteria with causing plaque accumulation in the
arteries. It hypothesized that microbes entered the plaques after they had formed (Koren, et al.,
2011). More studies need to be done regarding the possibility that some of the oral or gut
microbiota pathogens may be identified as ‘self’ by the immune system, and therefore spread
undetected to other areas of the body to cause chronic inflammation and disease.
Pathogens Identified as ‘Self” by the Immune System
Some of the oral pathogens that create plaque and calculus do not cause an immune
response. According to Nejat Duzgunes, PhD, in the book Medical Microbiology and
Immunology for Dentistry (2016), two oral pathogens, Streptococcal sanguinis and Streptococcal
gordonii ‘may appear to the immune system as “self”’ (Duzgunes, p.152). S sanguinis produces
an immunoglobulin A protease while S gordonii binds a-amylase which is the enzyme in the
saliva that breaks down starch. These two pathogens are commonly seen in endocarditis
infections. Research revealed involvement of putative lipoprotein PpiA which helped
Streptococcus gordonii in evasion of phagocytosis by macrophages (Cho, K., Arimoto, T.,
Igarashi, T. and Yamamoto, M., 2013). Evasion of the immune system by identification as ‘self’
or other means, allows the pathogens to proliferate, enter the bloodstream, and take up residence
in the heart valve and cause infective endocarditis. The author did not show how this pathogen
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was identified as ‘self’ by the body. (Duzgunes, 2016). Research should be done to determine if
S gordonii and S. Sanguinis are able to evade the immune response through identification by the
body as ‘self’ and not just through virulence factors or production of toxins (Gehrig, &Willman,
2016)
Conclusion

Research studies show that virulence factors for P. Gingivalis and many other microbes
are impressive in the ability that they have to evade detection by the immune system. The
purpose of this paper is not to deny that this is the case. Rather, it is to propose that it is possible
that a person may carry microbes that have been labeled by the immune system as ‘self’. In the
case of cancer, it has been proven that viruses can enter the body and produce cancerous tumors
that the immune system identifies as ‘self’. Scientists should consider the possibility that certain
microbes may not be identified as ‘foreign’ by the immune system, which could lead to disease.

Research studies have shown cases where the bacteria have not been identified as
antigens that elicit an immune response. Rather, the effect of the product or toxins produced by
the bacteria were what produced an immune response. If the body directs its immune response
toward the product of the bacteria, and not the bacteria itself, this could help explain chronic
inflammation, and lack of eradication of the pathogen by the body. More studies should be done
to determine if pathogens of the oral microbiome are identified as ‘self’ by the immature immune
system. Implications of oral pathogens being identified as ‘self,’ could be uninhibited access to
the body, resulting in chronic inflammation, and disease.
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